Health Care • Medical/Nursing Services
$1.45 ▼ -0.16
(-10.22%)
MKT CAP: $1.6M • VOL: 16.0K
52W L $1 52W H $74
ATPC // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.5M | $1.3M | $1.4M |
| YoY Revenue Growth % | +15.2% | -7.6% | — |
| Gross Profit | $838.3K | $759.1K | — |
| Gross Margin % | 55.0% | 57.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$3.3M | -$2.6M | -$2.1M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$2.3M | -$2.5M | -$2.1M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$2.4M | -$2.7M | -$2.0M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | -$2.4M | -$2.7M | -$2.0M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -11.5% | -45.0% | — |
| Cash & Short-Term Equivalents | $89.7K | $2.0M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $22.5M | $1.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ATPC.